Clinical Trials Logo

Recurrent Liver Carcinoma clinical trials

View clinical trials related to Recurrent Liver Carcinoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT03008343 Recruiting - Clinical trials for Recurrent Liver Carcinoma

Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer

Start date: December 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study is the safety and efficacy of irreversible electroporation (IRE) plus natural killer (NK) immunotherapy to recurrent liver cancer.

NCT ID: NCT02465060 Recruiting - Lymphoma Clinical Trials

NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma

Start date: August 12, 2015
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic abnormalities (such as mutations, amplifications, or translocations) may benefit more from treatment which targets their tumor's particular genetic abnormality. Identifying these genetic abnormalities first may help doctors plan better treatment for patients with solid tumors, lymphomas, or multiple myeloma.